The note is the current scenario (Base). Download PDF renders this page on the server, fonts and colours exact; Print uses the browser.
Model Note · iSERA LIFESCIENCES LIMITED · 11 September 2026Page 1 of 2
Model Note
Prepared by the reader · not a MarketPing document
iSERA LIFESCIENCES LIMITED
Discounted cash flow · base FY20

iSERA LIFESCIENCES LIMITED

Value per share, this model(6)
CMP 2026-09-09143.90
Difference(104.2)%
Growth the CMP implies45.0%/yr

This note states the assumptions and the arithmetic of one model of iSERA LIFESCIENCES LIMITED, built on its filed FY20 consolidated statements. The value is the outcome of the assumptions below and nothing else; it is not a fair value, a target or a recommendation.

Assumptions

InputThis modelFiled reference
Revenue growth, 5 years-5% a yearFY20 (91.7)% · 5-yr CAGR %
EBITDA margin-2.5%FY20 (2.5)% · 5-yr average (0.3)%
Depreciation · capex, % of revenue5.8% · 0%, fading to 1.2× depreciationFY20 5.8% · 0.0%
Working capital, % of added revenue · tax267.9% · 25.17%978 working-capital days · effective 25.2%
Discount rate11.00%1-yr beta 0.03
After FY255% flat · mid-year discounting
Net debt · non-controlling interest · non-operating investments7 · ₹0 · ₹0 crFY20 net debt ₹7 cr
Shares0.84 crore0.84 crore today
Source: SEBI results XBRL as filed with BSE/NSE, exchange prices; the reader's assumptions.

Projected cash flow to the firm

₹ croreFY20FY21FY22FY23FY24FY25
Revenue222222
growth %(91.7)(5.0)(5.0)(5.0)(5.0)(5.0)
EBITDA(0)(0)(0)(0)(0)(0)
Depreciation(0)(0)(0)(0)(0)(0)
NOPAT(0)(0)(0)(0)(0)(0)
less capex00(0)(0)(0)(0)
less working-capital build00000
Free cash flow to firm00000
Present value00000
Source: the model; base year as filed.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
Model Note · iSERA LIFESCIENCES LIMITED · 11 September 2026Page 2 of 2

From enterprise to equity

PV of the 5 explicit years1
PV of the terminal value (60% of EV)1
Enterprise value2
less net debt(7)
less non-controlling interest0
add non-operating investments0
Equity value(5)
÷ 0.84 crore shares(6)
Source: the model.

Sensitivity, ₹ per share

WACC ↓ · terminal growth →4.0%4.5%5.0%5.5%6.0%
10.0%(6)(6)(6)(5)(5)
10.5%(6)(6)(6)(6)(6)
11.0%(6)(6)(6)(6)(6)
11.5%(6)(6)(6)(6)(6)
12.0%(6)(6)(6)(6)(6)
Source: the model; n/a where terminal growth reaches the discount rate.

Statement

This note is the reader's own model over publicly filed information: SEBI results XBRL filed with BSE and NSE and exchange price data, assembled by MarketPing software; every assumption above is the reader's. It contains no research recommendation, no price target and no opinion by MarketPing on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Historical per-share figures are on the current share count. Where a figure is unavailable the table shows a dash rather than an estimate. Nothing here constitutes investment advice, an offer or a solicitation.

Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in